SPONSOR
H. Lee Moffitt Cancer Center and Research Institute
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 1
Conditions studied: Chronic Graft-versus-host Disease (cGVHD)Pediatric CancerPenile CarcinomaSkin CancerPancreatic CancerCancer CachexiaBreast CancerLeptomeningeal DiseaseMyelomaAcute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Chronic Graft-versus-host Disease (cGVHD), Pediatric Cancer, Penile Carcinoma, Skin Cancer.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — H. Lee Moffitt Cancer Center and Research Institute
How many clinical trials has H. Lee Moffitt Cancer Center and Research Institute sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by H. Lee Moffitt Cancer Center and Research Institute, of which 10 are actively recruiting participants. These trials cover conditions including Chronic Graft-versus-host Disease (cGVHD), Pediatric Cancer, Penile Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does H. Lee Moffitt Cancer Center and Research Institute research focus on?
H. Lee Moffitt Cancer Center and Research Institute clinical trials span Chronic Graft-versus-host Disease (cGVHD), Pediatric Cancer, Penile Carcinoma, Skin Cancer, Pancreatic Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a H. Lee Moffitt Cancer Center and Research Institute clinical trial?
To participate in a H. Lee Moffitt Cancer Center and Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all H. Lee Moffitt Cancer Center and Research Institute trials with current recruitment status updated daily.
Clinical Trials by H. Lee Moffitt Cancer Center and Research Institute
NCT06660355 Phase 2
Recruiting
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
NCT06423950
Recruiting
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Pediatric Cancer
NCT05526989 Phase 2
Recruiting
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Penile Carcinoma
NCT07222995
Recruiting
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
Skin Cancer
NCT07249775
Recruiting
A First-in-Human Study of FID-022 in Solid Tumor Patients
Pancreatic Cancer
NCT07694986 Phase 2
Recruiting
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Breast Cancer
NCT06947083 Phase 2
Recruiting
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
Myeloma
NCT06423963
Recruiting
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
Pancreatic Cancer
NCT05581030 Phase 1
Recruiting
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia
NCT06430346
Recruiting
Exercise Prehabilitation for Locoregional Esophageal Cancer
Esophageal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology